Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Diagnosis and Evaluation for Peritoneal Dialysis Patients
Diagnosis and evaluation are the cornerstones of successful peritoneal dialysis management, especially for patients traveling from abroad to receive care at Liv Hospital. Our multidisciplinary team conducts a thorough assessment that combines clinical history, laboratory testing, imaging, and functional studies to create a personalized treatment plan. Over 70% of international patients report improved outcomes when their initial assessment is comprehensive and coordinated.
In this guide we walk you through each step of the assessment process, explaining what tests are performed, why they matter, and how the results shape your dialysis regimen. Whether you are newly diagnosed with end‑stage renal disease or transitioning from hemodialysis, understanding the diagnosis and evaluation pathway helps you make informed decisions and prepares you for a smooth treatment experience at our JCI‑accredited facility.
Our approach is designed for the global patient community, offering interpreter services, virtual pre‑visit consultations, and assistance with travel logistics, ensuring that every aspect of your care journey is transparent and supportive.
Clinical Assessment and Patient History
The first phase of the diagnosis and evaluation process focuses on a detailed clinical interview and physical examination. Our nephrologists gather information about the patient’s medical background, lifestyle, and dialysis goals.
Key Elements Collected
- Duration and cause of chronic kidney disease
- Previous dialysis modalities and complications
- Comorbid conditions such as diabetes, hypertension, or cardiovascular disease
- Medication list, including over‑the‑counter and herbal supplements
- Social factors: travel plans, support network, and language preferences
A systematic physical exam evaluates volume status, peripheral edema, and signs of infection. Findings are documented in a structured template that facilitates communication across our international care team.
For patients arriving from abroad, we also verify vaccination status and screen for travel‑related health risks, integrating these considerations into the overall treatment strategy.
Laboratory Investigations and Biomarkers
Laboratory testing provides objective data that complement the clinical assessment. Our laboratory follows international standards and offers rapid turnaround for international patients.
Specialized biomarkers, such as β‑2 microglobulin, are ordered when we suspect dialysis‑related amyloidosis. All results are reviewed in a multidisciplinary meeting to determine suitability for peritoneal dialysis and to customize the prescription.
Imaging Studies and Diagnostic Imaging
Imaging helps visualize abdominal structures, assess catheter placement, and rule out contraindications. At Liv Hospital, we employ state‑of‑the‑art modalities that are safe for patients with compromised renal function.
Core Imaging Modalities
- Abdominal Ultrasound: Evaluates peritoneal membrane thickness, detects fluid collections, and confirms catheter tip location.
- Plain Abdominal X‑ray: Provides a quick check for catheter migration or bowel obstruction.
- CT Scan (non‑contrast): Reserved for complex cases where detailed anatomy is required, such as suspected intra‑abdominal adhesions.
Radiologists collaborate with nephrologists to interpret findings in real time, enabling immediate adjustments to the treatment plan. For international patients, digital imaging reports are uploaded to a secure portal, allowing remote review by referring physicians.
Peritoneal Membrane Function Tests
Assessing the transport characteristics of the peritoneal membrane is essential for tailoring dialysis prescriptions. The standard test performed at our center is the Peritoneal Equilibration Test (PET).
Peritoneal Equilibration Test (PET) Overview
- Procedure: A dialysis solution with 2.5% dextrose is infused, and dialysate samples are collected at 0, 2, and 4 hours.
- Parameters Measured: D/D₀ glucose ratio, D/P creatinine ratio, and ultrafiltration volume.
- Interpretation:
- High transporters: Rapid solute clearance but lower ultrafiltration—may need shorter dwell times.
- Low transporters: Slower clearance, higher ultrafiltration—benefit from longer dwell times.
Results are integrated with laboratory data to determine the optimal dwell schedule, dialysate concentration, and prescription volume. For patients transitioning from hemodialysis, the PET provides a baseline to monitor membrane changes over time.
Multidisciplinary Review and Treatment Planning
After gathering clinical, laboratory, imaging, and functional data, a multidisciplinary team convenes to finalize the diagnosis and evaluation outcome. The team includes nephrologists, surgeons, dietitians, psychologists, and patient‑care coordinators.
Decision‑Making Process
- Review of all diagnostic findings and identification of contraindications.
- Discussion of patient preferences, lifestyle, and travel schedule.
- Formulation of a personalized peritoneal dialysis regimen (CAPD vs. APD, dwell times, solution concentrations).
- Creation of an education plan covering catheter care, infection prevention, and emergency protocols.
- Scheduling of follow‑up assessments and remote monitoring options for international patients.
The final treatment plan is documented in a comprehensive report that is shared with the patient and, if desired, with their home‑country healthcare provider. This ensures continuity of care after discharge.
Preparing International Patients for Diagnosis and Evaluation
After gathering clinical, laboratory, imaging, and functional data, a multidisciplinary team convenes to finalize the diagnosis and evaluation outcome. The team includes nephrologists, surgeons, dietitians, psychologists, and patient‑care coordinators.
Decision‑Making Process
- Review of all diagnostic findings and identification of contraindications.
- Discussion of patient preferences, lifestyle, and travel schedule.
- Formulation of a personalized peritoneal dialysis regimen (CAPD vs. APD, dwell times, solution concentrations).
- Creation of an education plan covering catheter care, infection prevention, and emergency protocols.
- Scheduling of follow‑up assessments and remote monitoring options for international patients.
The final treatment plan is documented in a comprehensive report that is shared with the patient and, if desired, with their home‑country healthcare provider. This ensures continuity of care after discharge.
Frequently Asked Questions
What does the diagnosis and evaluation process for peritoneal dialysis involve?
The diagnosis and evaluation pathway at Liv Hospital begins with a detailed clinical assessment where the nephrologist records medical history, lifestyle, and dialysis goals. A physical examination follows to check volume status and signs of infection. Laboratory investigations provide objective data on kidney function, electrolytes, nutrition, and inflammation. Imaging studies—ultrasound, X‑ray, or non‑contrast CT—visualize the abdomen and catheter placement. Finally, the Peritoneal Equilibration Test evaluates membrane transport characteristics, allowing the team to tailor the dialysis prescription. All findings are reviewed by a multidisciplinary team to create a personalized treatment plan.
Which laboratory tests are essential before starting peritoneal dialysis?
Before initiating peritoneal dialysis, Liv Hospital orders a panel of labs to assess residual kidney function, nutritional status, and potential complications. Serum creatinine and eGFR determine remaining filtration capacity, while BUN measures nitrogen waste. Serum albumin evaluates protein nutrition, and a full electrolyte panel checks sodium, potassium, calcium, and phosphate levels that influence dialysis prescriptions. A complete blood count detects anemia or infection, and inflammatory markers such as CRP help screen for peritonitis risk. In selected cases, specialized biomarkers like β‑2 microglobulin are measured to identify dialysis‑related amyloidosis.
How is imaging used to assess suitability for peritoneal dialysis?
Liv Hospital employs several imaging modalities during the evaluation. Abdominal ultrasound assesses peritoneal membrane thickness, detects fluid collections, and verifies catheter tip location. A plain abdominal X‑ray offers a quick check for catheter migration or bowel obstruction. For complex cases, a non‑contrast CT scan provides detailed anatomy to identify intra‑abdominal adhesions or other issues that could impede dialysis. Radiologists collaborate with nephrologists in real time, allowing immediate adjustments to the treatment plan. All imaging reports are uploaded to a secure portal for remote review by referring physicians, ensuring continuity of care for international patients.
What is the Peritoneal Equilibration Test (PET) and why is it important?
The Peritoneal Equilibration Test involves infusing a 2.5% dextrose dialysis solution and sampling dialysate at 0, 2, and 4 hours. The test calculates the D/D₀ glucose ratio and D/P creatinine ratio, as well as ultrafiltration volume. High transporters clear solutes quickly but may have reduced ultrafiltration, requiring shorter dwell times. Low transporters clear solutes more slowly but achieve higher ultrafiltration, benefiting from longer dwells. PET results are integrated with lab data to customize dwell schedules, solution concentrations, and total volume. For patients transitioning from hemodialysis, PET provides a baseline to monitor membrane changes over time.
What factors are considered in the multidisciplinary treatment planning for peritoneal dialysis?
After gathering clinical, laboratory, imaging, and functional data, a multidisciplinary team—including nephrologists, surgeons, dietitians, psychologists, and care coordinators—convenes to finalize the treatment plan. They first verify that no contraindications exist based on the diagnostic work‑up. Patient preferences, daily routine, and upcoming travel are discussed to choose between CAPD and APD, determine dwell times, and select dialysate concentrations. An education plan covering catheter care, infection prevention, and emergency protocols is created. Follow‑up assessments and remote monitoring options are scheduled, especially for international patients, to maintain continuity after discharge.
